Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment
Objective: to comparatively assess the weighted average costs associated with the use of alogliptin-pioglitazone combination versus glucagon-like peptide-1 receptor agonists (GLP-1 RAs).Material and methods. A retrospective study involved pharmacoeconomic analysis, including cost-minimization analys...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2025-02-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|